In 2013, a workshop was held in Kathmandu that explored systematic reviews -what they are, how they are developed, how they are used in evidencebased clinical guidelines, and how they can inform the clinical research agenda. The workshop was funded by the Gates Foundation through FIGO, and organised by the Nepal Society of Obstetricians and Gynaecologists.
What are Systematic Reviews?
Reviews are important because busy clinicians rarely have time to read primary research reports and therefore rely on review articles, written by experts, to keep them up-to-date with the latest developments LQ WKHLU FKRVHQ ¿HOG +RZHYHU UHYLHZ DUWLFOHV FDQ be unreliable if the account is biased. A review author might, for example, have strong views about something -let's say, the advantages of surgical treatment of endometriosis compared to medical (drug) treatment. S/he might then selectively cite research papers that support surgery, and ignore those that support drug treatment, to strengthen the author's prior conviction that surgery is best.
'Systematic' reviews seek to avoid this problem by XVLQJ VFLHQWL¿F SULQFLSOHV WR PLQLPL]H ELDV 7KXV the systematic review is based around a clearly articulated question-to-be-addressed: such as 'what are the advantages and disadvantages of surgery versus medical treatment for endometriosis?'.
The methods of the review are then structured around the PICO approach -(P)opulation, (I)ntervention, (C) ontrol, (O)utcomes. The population here might be all women with endometriosis, or a sub-population with mild disease or with severe disease, or those with associated problems, e.g. infertility. The intervention would be surgical treatment; it could be all surgical methods or just laparoscopic procedures or just open operations. Control treatments (drugs here) could LQFOXGH DOO GUXJV RU VSHFL¿F VXEJURXSV RI GUXJV 7KH outcomes require careful consideration. These should include important symptoms: such as pelvic pain but a decision needs to be made about how pain would be measured, and when: 6 or 12 months after treatment, or later? Input by patients and other lay people can be extremely valuable in identifying clinically important outcome measures. Economic outcomes can also be important: surgery may be much more expensive (to both the health system and the patient) than simple drug treatment.
7KHUH LV FXUUHQWO\ PXFK LQWHUHVW LQ VWDQGDUGL]LQJ the outcomes used in clinical trials through the COMET Initiative (core outcome measures in effectiveness trials: http://www.comet-initiative.org ) and the CROWN Initiative (involving obstetrics and gynaecology journals). 1 7KH 3,&2 VWUXFWXUH LV ODLG RXW LQ DGYDQFH RI DQDO\]LQJ any data. Also set in advance are (1) the types of studies to be used in the systematic review, and (2) WKH ZD\ LQ ZKLFK WKHVH ZLOO EH LGHQWL¿HG 7KH W\SHV RI VWXGLHV DUH PRVW RIWHQ UDQGRPL]HG controlled trials (RCTs) although systematic reviews can also be done on other types of study e.g. observational or case control studies. RCTs are the gold standard studies to assess the effectiveness of healthcare interventions. They are so powerful because the act of randomly allocating patients (as long as it is done properly) produces two groups of patients which should be similar in most important respects, other than exposure to experimental treatment or control treatment. It is essential to avoid so-called µVHOHFWLRQ ELDV ¶ E\ HQVXULQJ WKDW UDQGRPL]DWLRQ XVHV a method such as sealed envelopes or, better still, computers, which means that the clinician cannot know in advance to which treatment group his/her patient will be allocated.
6WXGLHV LQ WKLV FDVH 5&7V DUH
LGHQWL¿HG WKURXJK D pre-set electronic search strategy. This may include papers in any language or be restricted (e.g. English language only). The important point is that ALL studies that meet the pre-set criteria for inclusion, are included. In this way, the review author cannot LQÀXHQFH WKH FRQFOXVLRQ RI KLVKHU DUWLFOH E\ VHOHFWLYH citation of research papers.
The objectives of the review, the PICO, and the search strategy and methods of analysis are laid down in advance as a 'protocol'. Only when this is ¿QLVKHG DUH WKH SDSHUV LGHQWL¿HG WKH GDWD H[WUDFWHG and the analyses performed. Most often, data from a number of similar RCTs are pooled together to give a composite result ('meta-analysis'). More robust results are obtained by increasing the total number of patients in the analyses through pooling.
The Cochrane Collaboration
The A gap of almost 15 years between the availability of evidence to show a particular treatment is highly effective, and its uptake into clinical practice, is manifestly not good enough. There are a many reasons for slow acceptance of innovations by clinicians, and by health systems. One method of speeding adoption of research into practice is through the development of evidence-based clinical guidelines, which rely heavily on systematic reviews. The World Health Organisation has produced a very helpful handbook on guideline development.
